Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar airenInDebt (56.97) Submitted: 12/30/2006 12:57:36 AM : Outperform Start Price: $10.67 ONXX Score: +340.04

I like drugs and I like them cheap. The company makes generic drugs! Yeah they had a set back, but who cares, there's plenty of sick (and not so sick) people who want their drugs!

Featured Broker Partners


Advertisement